Champalimaud Foundation

From Wikipedia, the free encyclopedia
Champalimaud Foundation
D. Anna de Sommer Champalimaud and Dr. Carlos Montez Champalimaud Foundation
Fundação D. Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud
AbbreviationFundação Champalimaud
Named afterAnna de Sommer Champalimaud and Carlos Montez Champalimaud
FormationJune 2005
FounderAntónio Champalimaud
Founded atLisbon
TypeNon-governmental organization
Registration no.507131827
Legal statusFoundation
PurposeScientific research in the field of medicine
HeadquartersCentro de Investigação da Fundação Champalimaud, Avenida Brasília, 1400-038 Lisbon
ServicesRadiology, Nuclear Medicine, Pathology, Radiation Oncology, Chemotherapy, and Psycho-oncology
Official language
Portuguese and English
Leonor Beleza
João Silveira Botelho
António Horta Osório
Key people
António Champalimaud and Leonor Beleza
Revenue (2018)
€ 70,234,226
Expenses (2018)€ 79,504,954
Endowment€ 500,000,000
Staff (2018)
Champalimaud Foundation building

The Champalimaud Foundation (Portuguese: Fundação Champalimaud) is a private biomedical research foundation. It was created according to the will of the late entrepreneur António de Sommer Champalimaud, in 2004. The complete name of the foundation honors the mother and father of the founder and is Fundação Anna de Sommer Champalimaud e Dr. Carlos Montez Champalimaud. It is located in Lisbon, Portugal.[1]


The mission of the Foundation is "to develop programmes of advanced biomedical research and provide clinical care of excellence, with a focus on translating pioneering scientific discoveries into solutions which can improve the quality of life of individuals around the world."

The foundation undertakes research in the fields of neuroscience and oncology at the modernistic Champalimaud Centre for the Unknown in Lisbon, opened in 2011. Research into visual impairment is undertaken via an outreach program.

The Champalimaud Clinical Center (CCC) is a modern scientific, medical and technological institution providing specialized clinical treatment for oncology. The Center develops advanced programs for research of diseases. The CCC tries to customize the therapies in order to achieve more effectiveness in controlling and treating the diseases.[2] It was designed by Indian architect Charles Correa.


The management of the Foundation consists of Board of Directors, General Council, Scientific Committee, Ethics Committee and Vision Award Jury. The acting President is Leonor Beleza appointed by António Champalimaud in his will.[3]

António Champalimaud Vision Award[edit]

The award was established in 2007 to recognise contributions to research into vision. In even numbered years it is awarded for contributions to overall vision research and in odd numbered years for contributions to the alleviation of visual problems, primarily in developing countries.[4]


Source: Champalimaud Foundation

See also[edit]


  1. ^ "Champalimaud Foundation". Champalimaud Foundation. Retrieved 23 June 2015.
  2. ^ "Clinic". Retrieved 2017-10-02.
  3. ^ "People". Retrieved 2017-10-02.
  4. ^ "Vision award". Champalimaud Foundation. Retrieved 7 November 2016.

External links[edit]